Consensus GlaxoSmithKline plc LIQUIDNET SYSTEMS

Equities

GSK

GB0009252882

Delayed LIQUIDNET SYSTEMS Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-0.40%	-.--%

01:30pm	GSK to Face Trials Over Zantac Cancer Allegations; Shares Tumble Pre-Bell	MT
01:26pm	GSK : Sell rating from JP Morgan	ZD

Evolution of the average Target Price on GlaxoSmithKline plc

Price target over the last 5 years

History of analyst recommendation changes

06068272137acf378103a6dab324363.3jhOJPPTW8ucB_qkvB5PuZ5TPdj975ycSygwXTZgxuc.vEsdRbTjEpHbYpOczlB87fY7DYipuMTlB0xFO3tVqq2MXB9etpg4jeVuwg~3cf710f648474706843a38e9e3480f0b

Analyst Recommendations on GlaxoSmithKline plc

GSK : Sell rating from JP Morgan	04:56pm	ZD
GSK : Deutsche Bank reiterates its Buy rating	04:38pm	ZD
GSK : Goldman Sachs remains Neutral	04:23pm	ZD
Goldman Sachs Starts GSK With Neutral Rating, $47 Price Target	30/05	MT
Goldman Sachs Initiates GlaxoSmithKline with Neutral Rating	30/05	MT
Jefferies and UBS cut Anglo American	30/05	AN
GSK : Upgraded to Neutral by Goldman Sachs	30/05	ZD
GSK executive buys GBP20,026 worth shares	20/05	AN
GSK: FOLLOWING SETTLEMENT OF PLACING, GSK WILL HAVE FULLY EXITED…	17/05	RE
LBBW Raises GSK PT, Reiterates Buy Rating	14/05	MT
DB and Berenberg raise Diploma price target	14/05	AN
Jefferies Keeps GSK at Buy, Lifts PT	13/05	MT
GSK : Deutsche Bank maintains a Buy rating	13/05	ZD
GSK : Receives a Buy rating from Jefferies	13/05	ZD
BAE Systems and Mondi cut to 'neutral'	13/05	AN
GSK : Receives a Buy rating from Bernstein	08/05	ZD
Bernstein Lifts GSK PT, Keeps Outperform Rating	08/05	MT
UBS raises Centrica to 'buy' from 'neutral	08/05	AN
GSK: CITIGROUP RAISES TARGET PRICE TO 2120P FROM 2100P…	08/05	RE
DZ Bank Keeps GSK at Hold, Raises PT	07/05	MT
AstraZeneca target raised; Antofagasta lowered	07/05	AN
GSK : UBS remains its Buy rating	06/05	ZD
GSK : DZ Bank remains Neutral	03/05	ZD
GSK : Buy rating from Deutsche Bank	02/05	ZD
GSK : UBS keeps its Buy rating	02/05	ZD

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

17.66 GBP

Average target price

20.26 GBP

Spread / Average Target

+14.69%

High Price Target

34.79 GBP

Spread / Highest target

+96.93%

Low Price Target

12 GBP

Spread / Lowest Target

-32.07%

Consensus detail

Consensus revision (last 18 months)

Analysts covering GlaxoSmithKline plc

Goldman Sachs
LBBW
Jefferies & Co.
DEUTSCHE BANK RESEARCH	Emmanuel Papadakis
JEFFERIES	Peter Welford
Bernstein
BERNSTEIN RESEARCH	Justin Smith
DZ BANK	Elmar Kraus
UBS
alphavalue	Abhishek Raval
JPMORGAN	James Gordon
Barclays
BERENBERG	Kerry Holford
Guggenheim
Citigroup
Deutsche Bank Securities
Morgan Stanley
Berenberg Bank
CREDIT SUISSE	Dominic Lunn
HSBC
Bank of America Securities/Merrill Lynch
Stifel Nicolaus
ODDO BHF
Societe Generale
Liberum Capital
J.P. Morgan Chase
DEUTSCHE BANK	Emmanuel Papadakis
KEPLER CHEUVREUX	David Evans
BAADER BANK
SVB Leerink
BANK OF AMERICA (BOFA)	Graham Parry

Ratings for GlaxoSmithKline plc

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar